Adlai Nortye (ANL) Debt Ratio (2022 - 2025)
Adlai Nortye's (ANL) quarterly Debt Ratio came in at 0.71 in Q4 2025, up 93.24% year-on-year from 0.37 in Q4 2024, and up 93.24% on a QoQ basis from 0.37 in Q4 2024.
Adlai Nortye (ANL) Debt Ratio (2022 - 2025) Analysis & Trends
Adlai Nortye (ANL) has 4 years of Debt Ratio data on file, last reported at 0.71 in Q4 2025.
- On a quarterly basis, Debt Ratio rose 93.24% year-over-year to 0.71 in Q4 2025; TTM through Dec 2025 was 0.71, a 93.24% increase from a year earlier, with the FY2025 full-year figure at 0.71, up 93.24% from the prior year.
- Debt Ratio for Q4 2025 stood at 0.71, up from 0.37 in the prior quarter.
- Over the last five years, Debt Ratio for ANL reached as high as 0.71 in Q4 2025 and fell as low as 0.06 in Q4 2022.
- Historically, Debt Ratio has averaged 0.34 across 4 years, with a median of 0.3 in 2024.
- Across the five-year window, Debt Ratio jumped 293.02% in 2023 and jumped 58.44% in 2024, its largest moves.
- Year by year, Debt Ratio stood at 0.06 in 2022, then soared by 293.02% to 0.23 in 2023, then soared by 58.44% to 0.37 in 2024, then surged by 93.24% to 0.71 in 2025.
- Per Business Quant data, the three most recent Debt Ratio figures were 0.71 in Q4 2025, 0.37 in Q4 2024, and 0.23 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 1.41 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.11 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.05 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Adlai Nortye | 1.27 Bn | 1.26 Bn | - | 0.71 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.71 |
| Dec 31, 2024 | 0.37 |
| Dec 31, 2023 | 0.23 |
| Dec 31, 2022 | 0.06 |